WHITEHAWK THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets
WHITEHAWK THERAPEUTICS, INC. (WHWK) reported Increase (Decrease) in Other Noncurrent Assets of -$325.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$162.00K, a 118.41% decline year-over-year.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$163.00K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$163.00K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$165.00K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was $438.00K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$518.00K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was -$518.00K.
- WHITEHAWK THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$437.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$162.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$325.00K 10-Q · filed 2026-08-06 | -$488.00K derived: sum of 3 quarters · filed 2026-08-06 | -$653.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$163.00K 10-Q · filed 2026-05-07 | -$326.00K derived: sum of 2 quarters · filed 2026-05-07 | -$491.00K derived: sum of 3 quarters · filed 2026-05-07 | $389.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$163.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$328.00K derived: sum of 2 quarters · filed 2026-03-12 | $552.00K derived: sum of 3 quarters · filed 2026-08-06 | $438.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | -$165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $715.00K derived: sum of 2 quarters · filed 2026-08-06 | $601.00K 10-Q · filed 2025-11-06 | $450.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $880.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $766.00K 10-Q · filed 2026-08-06 | $615.00K derived: sum of 3 quarters · filed 2026-08-06 | $501.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$114.00K 10-Q · filed 2026-05-07 | -$265.00K derived: sum of 2 quarters · filed 2026-05-07 | -$379.00K derived: sum of 3 quarters · filed 2026-05-07 | -$494.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$265.00K derived: sum of 2 quarters · filed 2026-03-12 | -$380.00K derived: sum of 3 quarters · filed 2026-03-12 | -$518.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$229.00K derived: sum of 2 quarters · filed 2025-11-06 | -$367.00K 10-Q · filed 2025-11-06 | -$487.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$253.00K 10-Q · filed 2025-08-07 | -$373.00K derived: sum of 3 quarters · filed 2025-08-07 | -$496.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$138.00K 10-Q · filed 2025-05-08 | -$258.00K derived: sum of 2 quarters · filed 2025-05-08 | -$381.00K derived: sum of 3 quarters · filed 2025-05-08 | -$540.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$243.00K derived: sum of 2 quarters · filed 2025-03-28 | -$402.00K derived: sum of 3 quarters · filed 2025-03-28 | -$518.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | -$123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$282.00K derived: sum of 2 quarters · filed 2024-11-06 | -$398.00K 10-Q · filed 2024-11-06 | -$470.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | -$159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$275.00K 10-Q · filed 2024-08-07 | -$347.00K derived: sum of 3 quarters · filed 2024-08-07 | -$428.00K derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$116.00K 10-Q · filed 2024-05-08 | -$188.00K derived: sum of 2 quarters · filed 2024-05-08 | -$269.00K derived: sum of 3 quarters · filed 2024-05-08 | -$428.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$153.00K derived: sum of 2 quarters · filed 2024-03-13 | -$312.00K derived: sum of 3 quarters · filed 2024-03-13 | -$437.00K 10-K · filed 2024-03-13 |
| 2022-09-30 | -$81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$240.00K derived: sum of 2 quarters · filed 2023-11-08 | -$365.00K 10-Q · filed 2023-11-08 | -$416.00K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$159.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$284.00K 10-Q · filed 2023-08-09 | -$335.00K derived: sum of 3 quarters · filed 2023-08-09 | -$765.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$125.00K 10-Q · filed 2023-05-10 | -$176.00K derived: sum of 2 quarters · filed 2023-05-10 | -$606.00K derived: sum of 3 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$481.00K derived: sum of 2 quarters · filed 2023-03-29 | -$481.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | -$430.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$430.00K 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | -$37.00K 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |